Skip to content
Lasa Supergenerics Ltd
  • Home
  • About us
    • Company Profile
    • Corporate Ethos
    • Our Strength
  • Products
    • API Products
      • Fenbendazole
      • Albendazole
      • Toldimphos Sodium
      • Cyromazine
      • Triciabendazole
      • Ricobendazole
      • Oxfendazole
      • Closantel Base
      • Closantel Sodium Dihydrate BP
      • Nitroxynil
      • Rafoxanide
      • Oxyclozanide
      • Ornidazole
      • Halquinol
      • 2,6-Diiodo-4-Nitrophenol
    • Other API Products
      • Albendazole
    • Animal Feed Ingredients
      • Calcium Iodate
    • Reagents For Therapeutic Use
      • Potassium Iodide
  • Investors
    • 9th Annual General Meeting
    • Key Financial Info
    • Board Of Directors
    • Management Team
    • Committees Of Directors
    • Listing Updates
    • Shared Information
    • Share Holding Pattern
    • Corporate Governance
    • Investors Contact
    • Code of Conduct
    • Brokerage Reports
    • Policies
    • Corporate Presentation
    • Postal Ballot
    • Half Yearly Compliances
    • Yearly Compliances
    • Secretarial Compliance
    • Downloads
  • Media
    • News & Press Releases
    • Corporate Announcements
    • Videos
  • Gallery
    • Listing Ceremony
    • Plant Photos
  • Blog
  • Contact us
Lasa Supergenerics Ltd
  • Home
  • About us
    • Company Profile
    • Corporate Ethos
    • Our Strength
  • Products
    • API Products
      • Fenbendazole
      • Albendazole
      • Toldimphos Sodium
      • Cyromazine
      • Triciabendazole
      • Ricobendazole
      • Oxfendazole
      • Closantel Base
      • Closantel Sodium Dihydrate BP
      • Nitroxynil
      • Rafoxanide
      • Oxyclozanide
      • Ornidazole
      • Halquinol
      • 2,6-Diiodo-4-Nitrophenol
    • Other API Products
      • Albendazole
    • Animal Feed Ingredients
      • Calcium Iodate
    • Reagents For Therapeutic Use
      • Potassium Iodide
  • Investors
    • 9th Annual General Meeting
    • Key Financial Info
    • Board Of Directors
    • Management Team
    • Committees Of Directors
    • Listing Updates
    • Shared Information
    • Share Holding Pattern
    • Corporate Governance
    • Investors Contact
    • Code of Conduct
    • Brokerage Reports
    • Policies
    • Corporate Presentation
    • Postal Ballot
    • Half Yearly Compliances
    • Yearly Compliances
    • Secretarial Compliance
    • Downloads
  • Media
    • News & Press Releases
    • Corporate Announcements
    • Videos
  • Gallery
    • Listing Ceremony
    • Plant Photos
  • Blog
  • Contact us

Corporate
Presentation

Investor Presentation 2020
LASA_FY 17-18
Lasa Supergenerics Ltd _Q3 FY18- Media Release
Lasa Supergenerics Ltd Investor Presentation
Transcript_Concall_FY20

Company

  • About us
  • Company Profile
  • Corporate Ethos
  • Our Strength

Facilities

  • Board of Directors
  • Management Team
  • Press Release
  • Announcements

Products

  • API Products
  • Other API Products
  • Animal Feed Ingredients
  • Reagents for Therapeutic Use

Contact Info

Plot no. C-4, C-4/1, MIDC Lote Parshuram Industrial Area, Tal -Khed, Khed Ratnagiri,
MH 415722 IN
info@lasalabs.com

Copyright © Lasa Supergenerics Ltd. 2021 | All Rights Reserved.
Website Designed by Magicwork Technologies